Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsRespiratory

ICU · Respiratory

Acute severe asthma in the ICU (status asthmaticus)

Also known as Status asthmaticus · Near-fatal asthma · Severe acute asthma · Magnesium sulphate for asthma · Volatile anaesthetic agents for asthma · Permissive hypercapnia · Dynamic hyperinflation / breath-stacking · Heliox in asthma

Status asthmaticus is severe acute asthma unresponsive to standard bronchodilator therapy. Features of life-threatening asthma: silent chest, exhaustion or drowsiness with hypercapnia, hypoxaemia (SpO2 <90% on ambient air), normal or rising PaCO2. Management: controlled oxygen (target SpO2 93-95% in asthma), repeated or continuous nebulised salbutamol + ipratropium, IV magnesium sulphate (2g over 20min), early systemic corticosteroids (prednisone 1mg/kg/day up to 50mg; oral and IV similarly effective). Mechanical ventilation: if required, use PERMISSIVE HYPERCAPNIA (small tidal volumes 6-8mL/kg IBW, low respiratory rate 10-12, long expiratory time, plateau pressure under 30 cmH2O) to avoid dynamic hyperinflation. Volatile anaesthetics (sevoflurane) as last-line bronchodilators. VV-ECMO for refractory near-fatal asthma - 83.5% survival in the ELSO registry analysis.

high21 referencesUpdated 3 Sept 202620 min readSource-verified · Sept 2026

Checked against its sources on 3 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Silent chest = no wheeze = NO AIR MOVING — pre-arrest sign, intubate NOW
  • Normal or rising PaCO2 in asthma = LIFE-THREATENING (should be low from hyperventilation)
  • Mechanical ventilation: PERMISSIVE HYPERCAPNIA — small Vt, low RR, long expiration. Avoid over-ventilation (dynamic hyperinflation → hypotension → arrest)
  • Hypotension immediately after starting ventilation = DYNAMIC HYPERINFLATION — DISCONNECT circuit, let exhale, resume at lower RR/Vt
  • Unilateral breath sounds + hypotension in ventilated asthma = TENSION PNEUMOTHORAX until proven otherwise
  • Beta-2 agonists cause HYPOKALAEMIA and LACTIC ACIDOSIS — do not misinterpret rising lactate as worsening asthma
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Silent chest = no wheeze = NO AIR MOVING — pre-arrest sign, intubate NOW
  • Normal or rising PaCO2 in asthma = LIFE-THREATENING (should be low from hyperventilation)
  • Mechanical ventilation: PERMISSIVE HYPERCAPNIA — small Vt, low RR, long expiration. Avoid over-ventilation (dynamic hyperinflation → hypotension → arrest)
  • Hypotension immediately after starting ventilation = DYNAMIC HYPERINFLATION — DISCONNECT circuit, let exhale, resume at lower RR/Vt
  • Unilateral breath sounds + hypotension in ventilated asthma = TENSION PNEUMOTHORAX until proven otherwise
  • Beta-2 agonists cause HYPOKALAEMIA and LACTIC ACIDOSIS — do not misinterpret rising lactate as worsening asthma
In one line

Status asthmaticus = severe asthma unresponsive to standard therapy. Life-threatening: silent chest, exhaustion/drowsiness, hypoxaemia (SpO2 <90% on ambient air), normal or rising PaCO2 with acidosis. Treatment: controlled O2 (target SpO2 93-95% in asthma), repeated or continuous nebulised salbutamol + ipratropium, IV magnesium 2 g over 20 min, early systemic steroids (prednisone 1 mg/kg/day up to 50 mg; oral = IV). Ventilation: permissive hypercapnia (pH ~7.25-7.30) — small Vt 6-8 mL/kg ideal body weight, low RR 10-12, long expiratory time, plateau pressure under 30 cmH2O. Avoid dynamic hyperinflation (causes hypotension and barotrauma). Volatile anaesthetics (sevoflurane) as last-line. VV-ECMO for refractory near-fatal asthma — 83.5% survival in the ELSO registry analysis.

[1] [5] [6] [11] [20]

Meet the patient

It is 03:40. A 28-year-old known asthmatic arrives in resus, blue around the lips, unable to speak beyond single words, RR 34, SpO2 86 per cent on 15 L NRB, HR 138. The chest is ominously quiet on auscultation — the registrar jokes "the wheeze has gone", and the consultant reaches for the bougie.[20][18]

Two facts decide the next hour. The silent chest is not improvement — it is no air movement, and the next ABG will almost certainly show a PaCO2 that is no longer low (the asthmatic who tires loses the respiratory alkalosis that should be reassuring). Sudden-asphyxic attacks are a distinct entity: in the classic series of ventilated status asthmaticus they presented with a silent chest on admission and extreme hypercapnia (mean PaCO2 112.8 mmHg).[20][18] Hold those two facts and the rest of this topic slots into place.

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References21ShowHide
  1. [1]Goodacre S, Cohen J, Bradburn M, et al. The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma Health Technol Assess, 2014.PMID 24731521
  2. [2]Goodacre S, Cohen J, Bradburn M, et al. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial Lancet Respir Med, 2013.PMID 24429154
  3. [3]Powell C, Kolamunnage-Dona R, Lowe J, et al. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial Lancet Respir Med, 2013.PMID 24429155
  4. [4]Kew KM, Kirtchuk L, Michell CI Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department Cochrane Database Syst Rev, 2014.PMID 24865567
  5. [5]Mein SA, Ferrera MC Management of Asthma and COPD Exacerbations in Adults in the ICU CHEST Crit Care, 2025.PMID 40330435
  6. [6]Darioli R, Perret C Mechanical controlled hypoventilation in status asthmaticus Am Rev Respir Dis, 1984.PMID 6703497
  7. [7]Leatherman J Mechanical ventilation for severe asthma Chest, 2015.PMID 26033128
  8. [8]Travers AH, Jones AP, Camargo CA Jr, et al. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma Cochrane Database Syst Rev, 2012.PMID 23235686
  9. [9]Soroksky A, Stav D, Shpirer I A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack Chest, 2003.PMID 12684289
  10. [10]Soroksky A, Klinowski E, Ilgyev E, et al. Noninvasive positive pressure ventilation in acute asthmatic attack Eur Respir Rev, 2010.PMID 20956164
  11. [11]Yeo HJ, Kim D, Jeon D, et al. Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry Crit Care, 2017.PMID 29212551
  12. [12]Ibarra CD, Sangiovanni S, Bautista DF, et al. Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series Multidiscip Respir Med, 2024.PMID 38476128
  13. [13]Ho GWK, Thaarun T, Ee NJ, et al. A systematic review on the use of sevoflurane in the management of status asthmaticus in adults Crit Care, 2024.PMID 39402635
  14. [14]Gorsky K, Cuninghame S, Jayaraj K, et al. Inhaled Volatiles for Status Asthmaticus, Epilepsy, and Difficult Sedation in Adult ICU and PICU: A Systematic Review Crit Care Explor, 2024.PMID 38384587
  15. [15]Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients Cochrane Database Syst Rev, 2006.PMID 17054154
  16. [16]Phoophiboon V, Singhagowinta P, Boonkaya S, et al. Salbutamol-induced lactic acidosis in status asthmaticus survivor 2021.PMID 33435939
  17. [17]Lalloo UG, Ainslie GM, Abdool-Gaffar MS, et al. Guideline for the management of acute asthma in adults: 2013 update S Afr Med J, 2012.PMID 23656743
  18. [18]Adan HAA, Dirie AMH Successful Non-Invasive Management of Near-Fatal Asthma with Severe Hypercapnic Respiratory Failure: A Case Report Int Med Case Rep J, 2025.PMID 41341505
  19. [19]Guo H, Zhao Q, Li SY, et al. Successful treatment of fatal asthma combined with a silent chest: A case report J Int Med Res, 2020.PMID 32466702
  20. [20]Wasserfallen JB, Schaller MD, Feihl F, et al. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis, 1990.PMID 2368957
  21. [21]Aslam SM, Shyllesh HA, Siddarth TsV, et al. Inadvertent Salbutamol Overdose Presenting as Acute Toxicity Cureus, 2025.PMID 41287681

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute respiratory failure: type 1 vs type 2, oxygen therapy, and when to intubateRespiratoryNextAcute severe community-acquired pneumonia: aspiration pneumonia updateRespiratory